Amarex timeline for Cytodyn:.. Dec. 4th, 2014..."

Amarex timeline for Cytodyn:..
Dec. 4th, 2014..."As an expert drug and device regulatory leader, Amarex's Kazem Kazempour is appointed to George Washington University's Regulatory Affairs Advisory Board. Two months later, Cytodyn signs an agreement with ACR
12/ 21, 2017, Amarex announces successful Orphan Drug Designation request filing on behalf of Cytodyn, inc. had been granted.
12/31, 2018 Amarex celebrates 20 yrs of clinical product dev. and approvals.
03/06, 2019 Amarex sets a record for successful US FDA submissions.
10/09, 2019, A majority investment by NSF in Amarex Research, LLC
03/20, 2020 Amarex assists with EUA for Covid-19 treatment (Leronlimab).
04/02, 2020 Treating Covid-19 with Leronlimab additional patients added to EUA.
04/23, 2020 Clinical trial for Severely ill Covid-19 patients is now enrolling.
04/28, 2020 Amarex submits a BLA on behalf of Cytodyn, a product to treat HIV
05/28, 2020 Amarex co-authors paper on EU of treatment of Covid-19.
08/21, 2020 Phase 2-mild-to-moderate Covid-19 study results for Pro140.
09/02, 2020 Amarex in the fight against Covid-19, repurposed HIV drug for Covid
01/18, 2021 Severe-t-critical Covid-19 patient trial reaches full enrollment (390).
09/10. 2021 Amarex to manage phase 2 clinical study of a new therapy for LH.
KINDA makes you wonder...at what point they twisted.